Dominik Papathanakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dominik Papathanakis has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christian Merle
Orthopädische Klinik Paulinenhilfe, Diakonie-Klinikum Stuttgart, Stuttgart, Germany
1 shared publication - Julian Deisenhofer
Orthopaedic University Hospital, University Hospital Heidelberg, Heidelberg, Germany
1 shared publication - Matthias Wolf
Universitätsklinikum Heidelberg, Orthopädische Universitätsklinik, Heidelberg, Germany
1 shared publication - Raphael Trefzer
Department of Orthopaedics Heidelberg University Hospital, Ruprecht‐Karls‐University Heidelberg Heidelberg Germany
1 shared publication - Tilman Walker
Department of Orthopaedics Heidelberg University Hospital Heidelberg Germany
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 507
Development of a simple clinical score to estimate in-hospital adverse event risk after elective hip arthroplasty: a retrospective cohort study in a high-risk population
Introduction: Patients undergoing total hip arthroplasty (THA) in tertiary centres often present with complex comorbidities that increase the risk of perioperative adverse events (AE). While fast-track and outpatient protocols are expanding, reliable risk stratification tools tailored to high-risk European populations remain limited. This study aimed to (1) compare comorbidity burden in a high-risk population to national data, (2) determine incidence and risk factors for in-hospital AE and (3) develop a simple, pragmatic score to identify patients at elevated AE risk. Materials and methods: We retrospectively analyzed 4,101 elective primary THA cases from a German tertiary care centre (2010–2019). Comorbidity burden was quantified using the Elixhauser Comorbidities (EC) and benchmarked against national registry data (EPRD). Independent predictors of in-hospital AE were identified using multivariate logistic regression. These variables were then used to develop a pragmatic preoperative clinical risk score via LASSO regression, internally validated with 10-fold cross-validation and bootstrapping. Results: Compared to the national registry, our cohort showed significantly higher rates of major comorbidities, including cardiac valvular disease, diabetes, and fluid/electrolyte disorders. The overall in-hospital AE rate was 2.6%. Six comorbidities—including pulmonary circulation disorders (OR 10.7, 95% CI: 3.6–31.8)—were independently associated with AE. The derived LASSO model demonstrated strong discrimination (AUC 0.80; 95% CI: 0.75–0.84) and calibration (Brier score 0.07). A cutoff score ≥ 2 identified patients with an AE rate of > 7%, while scores < 2 corresponded to an NPV of 0.99, supporting its utility in identifying low-risk patients for fast-track pathways. Conclusions: Patients treated in tertiary centres exhibit elevated comorbidity burden but maintain acceptable perioperative AE rate. A simple, validated clinical score can flag patients at substantially increased risk of in-hospital AE who may benefit from closer in-hospital surveillance and effectively identify low-risk candidates for fast-track THA pathways. Further external validation is warranted.
- 18 November 2025
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 507
Open AccessDevelopment of a simple clinical score to estimate in-hospital adverse event risk after elective hip arthroplasty: a retrospective cohort study in a high-risk population
Introduction: Patients undergoing total hip arthroplasty (THA) in tertiary centres often present with complex comorbidities that increase the risk of perioperative adverse events (AE). While fast-track and outpatient protocols are expanding, reliable risk stratification tools tailored to high-risk European populations remain limited. This study aimed to (1) compare comorbidity burden in a high-risk population to national data, (2) determine incidence and risk factors for in-hospital AE and (3) develop a simple, pragmatic score to identify patients at elevated AE risk. Materials and methods: We retrospectively analyzed 4,101 elective primary THA cases from a German tertiary care centre (2010–2019). Comorbidity burden was quantified using the Elixhauser Comorbidities (EC) and benchmarked against national registry data (EPRD). Independent predictors of in-hospital AE were identified using multivariate logistic regression. These variables were then used to develop a pragmatic preoperative clinical risk score via LASSO regression, internally validated with 10-fold cross-validation and bootstrapping. Results: Compared to the national registry, our cohort showed significantly higher rates of major comorbidities, including cardiac valvular disease, diabetes, and fluid/electrolyte disorders. The overall in-hospital AE rate was 2.6%. Six comorbidities—including pulmonary circulation disorders (OR 10.7, 95% CI: 3.6–31.8)—were independently associated with AE. The derived LASSO model demonstrated strong discrimination (AUC 0.80; 95% CI: 0.75–0.84) and calibration (Brier score 0.07). A cutoff score ≥ 2 identified patients with an AE rate of > 7%, while scores < 2 corresponded to an NPV of 0.99, supporting its utility in identifying low-risk patients for fast-track pathways. Conclusions: Patients treated in tertiary centres exhibit elevated comorbidity burden but maintain acceptable perioperative AE rate. A simple, validated clinical score can flag patients at substantially increased risk of in-hospital AE who may benefit from closer in-hospital surveillance and effectively identify low-risk candidates for fast-track THA pathways. Further external validation is warranted.